Clinical

Clinical, Original Research
Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor
JoAnne Foody, MD; Robin S. Turpin, PhD; Beni A. Tidwell, BS; Debra Lawrence, PhD; Kathy L. Schulman, MS
Stakeholder Perspective
The Growing Role of Real-World Evidence in Clinical Decision-Making
Gary M. Owens, MD
Read More
Clinical, Original Research
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide
Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Dominic Pilon, MA; Yongling Xiao, PhD; Patrick Lefebvre, MA
Stakeholder Perspective
A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management
Gary M. Owens, MD
Read More
Clinical, Original Research
The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data
Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH
Stakeholder Perspective
Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs
JoAnn V. Pinkerton, MD, FACOG, NCMP
Read More
Clinical
The Medical and Economic Burden of Narcolepsy: Implications for Managed Care
Michael J. Thorpy, MB, ChB; George Hiller, RPh
Stakeholder Perspective
Improved Diagnosis and Treatment of Narcolepsy May Also Help to Reduce the Associated Costs
James T. Kenney, RPh, MBA
Read More
Clinical, Original Research
Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
Kelvin Lingjet Tran, DO; Young In Park, DO; Shalin Pandya, DO; Navin John Muliyil, DO; Brandon David Jensen, DO; Kovin Huynh, DO; Quang T. Nguyen, DO, FACP, FACE, FTOS
Stakeholder Perspective
The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
Raymond Plodkowski, MD
Read More
Clinical, Original Research
Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas
Kelly F. Bell, PharmD, MSPhr, MS; Katherine Cappell, PhD; Michael Liang, MS; Amanda M. Kong, MPH
Stakeholder Perspective
Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence
Brian Caveney, MD, JD, MPH
Read More
Clinical
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm
Jordan S. Orange, MD, PhD; Matt Johnson, BA; Barb Lennert, RN, BSN, MAOM; Katarzyna Shields, PharmD, MBA, BCOP, BCPS; Michael Eaddy, PharmD, PhD
Stakeholder Perspective
A Useful Tool for Evaluating Disease Severity and Alternative Treatments Efficacy
Gary Branning, MBA
Read More
Clinical
Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy
Dominic Pilon, MA; Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Marie-Noëlle Robitaille, MA; Patrick Lefebvre, MA; Nancy A. Dawson, MD
Stakeholder Perspective
Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer
Brian Caveney, MD, JD, MPH
Read More
Clinical, Original Research
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD, MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA
Stakeholder Perspective
The Challenge of Rosacea Treatment
Atheer A. Kaddis, PharmD
Read More
Clinical, Original Research
Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis
Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS
Stakeholder Perspective
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Jack E. Fincham, PhD, RPh
Read More
Page 5 of 15
Results 41 - 50 of 144
SUBSCRIBE
© Amplity Health. All rights reserved.